Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Sweetens Its Bid For Metsera

Digest more
 · 3h · on MSN
Novo Nordisk downgrades sales outlook again amid bidding war with Pfizer for Metsera
In late morning trade, the stock edged up by 1% in Copenhagen.

Continue reading

 · 22h · on MSN
Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer
 · 21h
Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera
2h

Novo Nordisk's Medicare deal takes heat off Wegovy slowdown

COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and sales forecasts on Wednesday as sales growth ...
Investing.com South Africa
6d

Novo Nodrisk stock dips on aggressive odder to buy Metsera, ’reckless’ says Pfizer

Investing.com -- Novo Nordisk shares have slipped over 2% premarket on Thursday after the company made an unsolicited bid to ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Trending now

Wins NYC mayor’s race
Wins VA governor's race
UPS plane crashes in KY
US warns of 'mass chaos'
Maine voters OK red flag law
Starts redistricting process
Charged w/ securities fraud
Fire at retiree boarding house
Wins NJ governor's race
Parent company explores sale
Trump on SNAP payments
US strikes alleged drug boat
Calls for ‘deep reflection’
Six Flags America closes
CA voters OK new map
Sign extension through 2029
Light of 10 trillion suns
Transitions to new leadership
US-Switzerland trade talks
To cut thousands of jobs
Two MA men arrested
Renominated by Trump
To build AI factory
Todd Snider cancels tour
To be taken private
Chrysler recalls 320K+ SUVs
Shenzhou-20 return delayed
Feedback
  • Privacy
  • Terms